Prostate Cancer

Prostate cancer is the most common cancer and the second leading cause of cancer death among men in the United States, with about 1 in 5 men diagnosed with it in the US. Prostate cancer usually grows very slowly and can go undetected. Although finding and treating it before symptoms occur may not improve men’s health or help them live longer, the disease has a 97.8% 5-year survival rate. 

Current diagnostic tests for prostate cancer include physical exams, digital rectal exams, prostate-specific antigen (PSA) tests, ultrasound imaging, or MRI. It is not uncommon to employ watchful waiting and active surveillance as the first step in treatment until the cancer begins to grow and requires additional treatment.

Researchers

Wawrzyniec Dobrucki

Wawrzyniec Dobrucki

Associate Professor, Bioengineering

Jiawei Han

Jiawei Han

Professor, Computer Science

John Katzenellenbogen

John Katzenellenbogen

Professor, Chemistry

Erik Nelson

Erik Nelson

Program Leader, Cancer Discovery Platforms (CDP)

Associate Professor, Molecular & Integrative Physiology

Shuming Nie

Shuming Nie

Professor, Bioengineering

Taher Saif

Taher Saif

Professor, Mechanical Science & Engineering

Andrew Smith

Andrew Smith

Associate Professor, Bioengineering

Rebecca Smith

Rebecca Smith

Associate Professor, Pathobiology

Gregory Underhill

Gregory Underhill

Associate Professor, Bioengineering

Related News

Departments

Materials Science & Engineering, Bioengineering, Computer Science, Chemistry, Mechanical Science & Engineering, Pathobiology